Cabaletta Bio Stock Buy Hold or Sell Recommendation
| CABA Stock | USD 4.91 0.06 1.24% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Cabaletta Bio is 'Strong Sell'. Macroaxis provides Cabaletta Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CABA positions.
Check out Cabaletta Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide. In addition, we conduct extensive research on individual companies such as Cabaletta and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Cabaletta |
Execute Cabaletta Bio Buy or Sell Advice
The Cabaletta recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cabaletta Bio. Macroaxis does not own or have any residual interests in Cabaletta Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cabaletta Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Cabaletta Bio Trading Alerts and Improvement Suggestions
| Cabaletta Bio generated a negative expected return over the last 90 days | |
| Cabaletta Bio has high historical volatility and very poor performance | |
| Net Loss for the year was (67.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Cabaletta Bio currently holds about 96.81 M in cash with (53.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34. | |
| Cabaletta Bio has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: State Street Corps Strategic Reduction in Cabaletta Bio Inc Holdings |
Cabaletta Bio Returns Distribution Density
The distribution of Cabaletta Bio's historical returns is an attempt to chart the uncertainty of Cabaletta Bio's future price movements. The chart of the probability distribution of Cabaletta Bio daily returns describes the distribution of returns around its average expected value. We use Cabaletta Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cabaletta Bio returns is essential to provide solid investment advice for Cabaletta Bio.
| Mean Return | -0.3 | Value At Risk | -8.01 | Potential Upside | 8.23 | Standard Deviation | 6.78 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cabaletta Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cabaletta Stock Institutional Investors
| Shares | Sofinnova Ventures | 2024-06-30 | 1.2 M | Stempoint Capital Lp | 2024-06-30 | 1.2 M | Commodore Capital Lp | 2024-06-30 | 1.1 M | Geode Capital Management, Llc | 2024-06-30 | 970.6 K | Jpmorgan Chase & Co | 2024-06-30 | 956.7 K | Millennium Management Llc | 2024-06-30 | 698.3 K | Victory Capital Management Inc. | 2024-06-30 | 634.2 K | Perceptive Advisors Llc | 2024-06-30 | 585 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 582.3 K | Jennison Associates Llc | 2024-06-30 | 5.5 M | Blackrock Inc | 2024-06-30 | 4.8 M |
Cabaletta Bio Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 103.2M | (34.8M) | 20.8M | (40.6M) | 111.6M | 117.2M | |
| Other Non Cash Items | (105.9M) | 119K | 62K | 2.8M | 2.9M | 3.1M | |
| Net Income | (16.9M) | (33.3M) | (46.3M) | (53.0M) | (67.7M) | (64.3M) | |
| End Period Cash Flow | 136.2M | 101.4M | 122.2M | 81.6M | 193.2M | 104.9M | |
| Change To Netincome | 2.3M | 4.5M | 5.9M | 6.9M | 6.2M | 4.7M | |
| Free Cash Flow | (16.7M) | (27.4M) | (35.3M) | (48.8M) | (54.2M) | (51.5M) |
Cabaletta Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cabaletta Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cabaletta Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cabaletta stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.4 | |
β | Beta against Dow Jones | 1.06 | |
σ | Overall volatility | 6.83 | |
Ir | Information ratio | -0.06 |
Cabaletta Bio Volatility Alert
Cabaletta Bio is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cabaletta Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cabaletta Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cabaletta Bio Fundamentals Vs Peers
Comparing Cabaletta Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cabaletta Bio's direct or indirect competition across all of the common fundamentals between Cabaletta Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cabaletta Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cabaletta Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Cabaletta Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cabaletta Bio to competition |
| Fundamentals | Cabaletta Bio | Peer Average |
| Return On Equity | -0.48 | -0.31 |
| Return On Asset | -0.31 | -0.14 |
| Current Valuation | 43.78 M | 16.62 B |
| Shares Outstanding | 48.85 M | 571.82 M |
| Shares Owned By Insiders | 3.09 % | 10.09 % |
| Shares Owned By Institutions | 96.91 % | 39.21 % |
| Number Of Shares Shorted | 5.32 M | 4.71 M |
| Price To Earning | (3.33) X | 28.72 X |
| Price To Book | 1.20 X | 9.51 X |
| EBITDA | (73.23 M) | 3.9 B |
| Net Income | (67.67 M) | 570.98 M |
| Cash And Equivalents | 96.81 M | 2.7 B |
| Cash Per Share | 3.34 X | 5.01 X |
| Total Debt | 5.02 M | 5.32 B |
| Debt To Equity | (3.76) % | 48.70 % |
| Current Ratio | 15.22 X | 2.16 X |
| Book Value Per Share | 4.13 X | 1.93 K |
| Cash Flow From Operations | (53.55 M) | 971.22 M |
| Short Ratio | 5.41 X | 4.00 X |
| Earnings Per Share | (1.91) X | 3.12 X |
| Target Price | 22.9 | |
| Number Of Employees | 136 | 18.84 K |
| Beta | 2.39 | -0.15 |
| Market Capitalization | 239.6 M | 19.03 B |
| Total Asset | 253.65 M | 29.47 B |
| Retained Earnings | (233.24 M) | 9.33 B |
| Working Capital | 228.5 M | 1.48 B |
| Current Asset | 30.42 M | 9.34 B |
| Current Liabilities | 843.74 K | 7.9 B |
| Net Asset | 253.65 M |
Note: Acquisition by Nichtberger Steven of 333500 shares of Cabaletta Bio at 11.47 subject to Rule 16b-3 [view details]
Cabaletta Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cabaletta . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cabaletta Bio Buy or Sell Advice
When is the right time to buy or sell Cabaletta Bio? Buying financial instruments such as Cabaletta Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cabaletta Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Energy Funds Thematic Idea Now
Energy Funds
Funds or Etfs investing in energy sector, natural resources, and ecology. The Energy Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Cabaletta Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Return On Assets (0.31) | Return On Equity (0.48) |
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.